Unknown

Dataset Information

0

Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism.

ABSTRACT: SLC1A2 is a trimeric transporter essential for clearing glutamate from neuronal synapses. Recurrent de novo SLC1A2 missense variants cause a severe, early onset developmental and epileptic encephalopathy via an unclear mechanism. We demonstrate that all 3 variants implicated in this condition localize to the trimerization domain of SLC1A2, and that the Leu85Pro variant acts via a dominant negative mechanism to reduce, but not eliminate, wild-type SLC1A2 protein localization and function. Finally, we demonstrate that treatment of a 20-month-old SLC1A2-related epilepsy patient with the SLC1A2-modulating agent ceftriaxone did not result in a significant change in daily spasm count. ANN NEUROL 2019;85:921-926.

SUBMITTER: Stergachis AB 

PROVIDER: S-EPMC6800210 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

SLC1A2 is a trimeric transporter essential for clearing glutamate from neuronal synapses. Recurrent de novo SLC1A2 missense variants cause a severe, early onset developmental and epileptic encephalopathy via an unclear mechanism. We demonstrate that all 3 variants implicated in this condition localize to the trimerization domain of SLC1A2, and that the Leu85Pro variant acts via a dominant negative mechanism to reduce, but not eliminate, wild-type SLC1A2 protein localization and function. Finally  ...[more]

Similar Datasets

Unknown Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema.
| S-EPMC6307969 | biostudies-literature
Unknown A dominant-negative mutant inhibits multiple prion variants through a common mechanism.
| S-EPMC5679637 | biostudies-literature
Unknown Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy.
| S-EPMC4457960 | biostudies-literature
Unknown Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism.
| S-EPMC5379862 | biostudies-literature
Unknown Dominant negative effects of SCN5A missense variants.
| S-EPMC9262418 | biostudies-literature
Unknown Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features.
| S-EPMC2606053 | biostudies-literature
Unknown Dominant-negative mechanism of leukemogenic PAX5 fusions.
| S-EPMC3197879 | biostudies-literature
Unknown Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.
| S-EPMC8273149 | biostudies-literature
Unknown CACNA1H variants are not a cause of monogenic epilepsy.
| S-EPMC7301766 | biostudies-literature
Unknown Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.
| S-EPMC7261753 | biostudies-literature